Givaudan SA Total Liabilities
Givaudan SA total liabilities. Based on the latest financial reports, Givaudan SA (GIVN) has total liabilities worth CHF7.68 Billion CHF (≈ $9.71 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check GIVN asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Givaudan SA (2002–2025)
Total liabilities of Givaudan SA from 2002 to 2025. This chart illustrates how Givaudan SA's total liabilities have evolved over time, based on quarterly financial data. Explore GIVN long-term investments to assets to see how much of total assets are deployed in long-term investments.
Givaudan SA Competitors by Total Liabilities
The table below lists competitors of Givaudan SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Atmos Energy Corporation
NYSE:ATO
|
USA | $4.44 Billion |
|
Royalty Pharma Plc
NASDAQ:RPRX
|
USA | $9.88 Billion |
|
Pembina Pipeline Corp
TO:PPL
|
Canada | CA$19.27 Billion |
|
Credicorp Ltd
NYSE:BAP
|
USA | $243.59 Billion |
|
Fresenius SE & Co. KGaA
XETRA:FRE
|
Germany | €23.19 Billion |
|
HOCHTIEF Aktiengesellschaft
F:HOT
|
Germany | €26.83 Billion |
|
China National Nuclear Power
SHG:601985
|
China | CN¥503.95 Billion |
|
Cheniere Energy Partners LP
NYSE:CQP
|
USA | $17.03 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down Givaudan SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see GIVN current and non-current assets.
Liquidity & Leverage Metrics
Givaudan SA Total Liabilities Ratios Explained
Givaudan SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Givaudan SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Givaudan SA (2002–2025)
The table below shows the annual total liabilities of Givaudan SA from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CHF7.30 Billion ≈ $9.22 Billion |
-2.99% |
| 2024-12-31 | CHF7.52 Billion ≈ $9.51 Billion |
+5.48% |
| 2023-12-31 | CHF7.13 Billion ≈ $9.01 Billion |
-1.95% |
| 2022-12-31 | CHF7.27 Billion ≈ $9.19 Billion |
-2.95% |
| 2021-12-31 | CHF7.49 Billion ≈ $9.47 Billion |
+4.80% |
| 2020-12-31 | CHF7.15 Billion ≈ $9.04 Billion |
+6.13% |
| 2019-12-31 | CHF6.74 Billion ≈ $8.52 Billion |
+21.50% |
| 2018-12-31 | CHF5.54 Billion ≈ $7.01 Billion |
+47.04% |
| 2017-12-31 | CHF3.77 Billion ≈ $4.77 Billion |
+17.08% |
| 2016-12-31 | CHF3.22 Billion ≈ $4.07 Billion |
+12.35% |
| 2015-12-31 | CHF2.87 Billion ≈ $3.62 Billion |
-6.28% |
| 2014-12-31 | CHF3.06 Billion ≈ $3.87 Billion |
+10.08% |
| 2013-12-31 | CHF2.78 Billion ≈ $3.51 Billion |
+4.08% |
| 2012-12-31 | CHF2.67 Billion ≈ $3.38 Billion |
-17.11% |
| 2011-12-31 | CHF3.22 Billion ≈ $4.07 Billion |
-7.36% |
| 2010-12-31 | CHF3.48 Billion ≈ $4.40 Billion |
-18.59% |
| 2009-12-31 | CHF4.27 Billion ≈ $5.40 Billion |
-12.91% |
| 2008-12-31 | CHF4.90 Billion ≈ $6.20 Billion |
-5.96% |
| 2007-12-31 | CHF5.21 Billion ≈ $6.59 Billion |
+173.90% |
| 2006-12-31 | CHF1.90 Billion ≈ $2.41 Billion |
-8.42% |
| 2005-12-31 | CHF2.08 Billion ≈ $2.63 Billion |
-11.23% |
| 2004-12-31 | CHF2.34 Billion ≈ $2.96 Billion |
+19.37% |
| 2003-12-31 | CHF1.96 Billion ≈ $2.48 Billion |
+9.30% |
| 2002-12-31 | CHF1.79 Billion ≈ $2.27 Billion |
-- |
About Givaudan SA
Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & … Read more